Quantcast
Channel: National Bleeding Disorders Foundation - for all blood and bleeding disorders
Browsing latest articles
Browse All 616 View Live

New Jersey Chapter Fights for Critical State Legislation

Stephanie Lapidow, Executive Director of the Hemophilia Association of New Jersey (HANJ), is leading the charge to protect patients from predatory insurance practices through critical state legislation...

View Article


Breaking News: Takeda Announces Discontinuation of Two Hemophilia Treatments

Takeda Pharmaceuticals announced today it will globally discontinue two of its hemophilia treatments: HEMOFIL® M [Antihemophilic Factor (Human), Method M, Monoclonal Purified] and RECOMBINATE®...

View Article


Happy National Social Work Month from the NFRC

Welcome to the Resource Round Up (formerly HANDI Highlights), a periodic communication of the Neil Frick Resource Center (NFRC), designed to connect the bleeding disorders community with practical and...

View Article

2025 Scholarships List is Up!

The Neil Frick Resources Center (NFRC) is excited to announce new 2025 scholarship opportunities available to the bleeding disorders community. 

View Article

NBDF Expands Health Access Initiatives Through Strategic Department Evolution

For Immediate Release PRESS CONTACT:  Kyla Clark National Bleeding Disorders Foundation 

View Article


Paper Finds Bone Health Screening Rates at HTCs Represent Clinical Care Gap

The topic of bone health in people with bleeding disorders has received more attention and study in recent years, with reports suggesting that people with hemophilia (PwH) and people with von...

View Article

AN IMPORTANT UPDATE FROM NBDF'S PRESIDENT & CEO

Dear Friends,

View Article

Government Relations Update - March 2025

Federal:  Washington Days  On March 6, over 400 advocates from the bleeding disorders community were in Washington, DC to meet with their legislators and their staff about issues important to the...

View Article


FDA Approves Qfitlia: New Hemophilia Therapy Breakthrough

The U.S. Food and Drug Administration (FDA) recently approved Qfitlia™ (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12...

View Article


Take Action: Protect Bleeding Disorder Programs

We need your help again! Earlier this week, the Administration announced drastic changes and reductions to the federal health programs that support the bleeding disorders community. We talked about the...

View Article
Browsing latest articles
Browse All 616 View Live